Full Press Release Details
REGENERON COMPLETES ENROLLMENT FOR IL-1 TRAP PHASE 3 TRIAL IN AUTOINFLAMMATORY DISEASE Efficacy Phase of Trial on Target for Completion in 2006.
REGN
REGENERON COMPLETES ENROLLMENT FOR IL-1 TRAP PHASE 3 TRIAL IN AUTOINFLAMMATORY DISEASE Efficacy Phase of Trial on Target for Completion in 2006
Key Takeaway: REGENERON COMPLETES ENROLLMENT FOR IL-1 TRAP PHASE 3 TRIAL IN AUTOINFLAMMATORY DISEASE Efficacy Phase of Trial on Target for Completion in 2006